Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04132440
What this trial is testing

Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseasePhysician
M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00063622
What this trial is testing

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)

Who this might be right for
Liver Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 247
Testing effectiveness (Phase 2)Study completedNCT05591079
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Cascade Pharmaceuticals, Inc 99
Testing effectiveness (Phase 2)Study completedNCT04929483
What this trial is testing

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 222
Not applicableUnknownNCT05029583
What this trial is testing

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Who this might be right for
Nonalcoholic SteatohepatitisType 2 Diabetes
LMC Diabetes & Endocrinology Ltd. 5,000
Not applicableUnknownNCT05220956
What this trial is testing

Impact of Time-restricted Feeding in NAFLD

Who this might be right for
Fatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic
Johannes Gutenberg University Mainz 100
Not applicableUnknownNCT04653103
What this trial is testing

NASH in Subjects With Different Classes of Obesity

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDObesity+1 more
Catholic University of the Sacred Heart 500
Not applicableStudy completedNCT00771108
What this trial is testing

Exercise Dose and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Washington University School of Medicine 33
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Large-scale testing (Phase 3)Study completedNCT03723252
What this trial is testing

Dapagliflozin Efficacy and Action in NASH

Who this might be right for
Nonalcoholic Steatohepatitis
Nanfang Hospital, Southern Medical University 154
Testing effectiveness (Phase 2)Study completedNCT03256526
What this trial is testing

6-week Safety and PD Study in Adults With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Pfizer 53
Not applicableStudy completedNCT01045499
What this trial is testing

LAGB as a Treatment for Morbid Obesity in Adolescents

Who this might be right for
Morbid ObesityObstructive Sleep Apnea SyndromeMetabolic Syndrome+2 more
Jeffrey L Zitsman, MD 137
Not applicableWithdrawnNCT03864835
What this trial is testing

NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06160271
What this trial is testing

Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Central Hospital, Nancy, France 72
Not applicableStudy completedNCT02962297
What this trial is testing

Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

Who this might be right for
NASH (Non-Alcoholic Steatohepatitis)
Zhejiang Medicine Co., Ltd. 120
Not applicableLooking for participantsNCT05625750
What this trial is testing

Observational Study About Patients Diagnosed With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease
Xiangya Hospital of Central South University 500
Testing effectiveness (Phase 2)Study completedNCT05364684
What this trial is testing

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDNonalcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00799578
What this trial is testing

A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty Liver
Joel Lavine 13
Not applicableEnrolling By InvitationNCT00983463
What this trial is testing

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver Disease
Vanderbilt University 45
Next Page